Lac operon
Lac operon is a genetic regulatory system found in Escherichia coli (E. coli) and some other bacteria. It consists of a series of genes which are responsible for the metabolism of lactose in these organisms. The lac operon was first described by François Jacob and Jacques Monod in 1961, who were awarded the Nobel Prize in Physiology or Medicine for their work in 1965.
Structure[edit | edit source]
The lac operon consists of three structural genes, and a promoter, a terminator, regulator, and an operator. The three structural genes are: lacZ, lacY, and lacA.
- lacZ codes for beta-galactosidase, an enzyme that cleaves lactose into glucose and galactose.
- lacY codes for permease, a protein that aids in the transport of lactose into the cell.
- lacA codes for transacetylase, an enzyme that transfers an acetyl group from acetyl-CoA to beta-galactosides.
Regulation[edit | edit source]
The lac operon is regulated by several factors including the availability of glucose and lactose. It is an example of a negative control system because it is regulated by a repressor, the lacI gene product, which inhibits transcription. When lactose is present, it is converted into allolactose, which inhibits the repressor, allowing transcription to occur.
Induction and Repression[edit | edit source]
In the absence of lactose, the lac repressor binds to the operator region of the operon and prevents transcription of the downstream genes. When lactose is present, it binds to the repressor, causing a conformational change that makes it unable to bind to the operator. This is known as induction.
In the presence of glucose, the bacterium will suppress the lac operon to use the more energetically favorable glucose. This is known as catabolite repression.
Significance[edit | edit source]
The discovery of the lac operon has been fundamental to our understanding of gene regulation. It was the first genetic regulatory system to be understood in detail and has served as a model for the study of other genetic regulatory systems.
See also[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
